RxDoctor Payments Data

David Bearss, MD

Pediatrics · Salisbury, NCNPI 1063408235

Payments from drug & device makers

$1,465in general payments, 2019–2025

Across 27 payments — averaging $54.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$592
  • Pfizer$363
  • Amgen$228
  • Johnson & Johnson$86
  • Sanofi-aventis U.S. LLC$80
  • AstraZeneca$70
  • plus $47 from 2 others

What the payments were for

  • Food & beverage$1,465100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,465 in reported general payments places this provider in the 85th percentile of 1,818 pediatrics providers in North Carolina.

See all pediatrics providers in North Carolina

Medicare billing

Part B allowed, 2024
$92,661
Medicare patients
211
Services billed
1,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban180$168,643
JardianceEmpagliflozin157$114,797
OzempicSemaglutide77$88,901
XareltoRivaroxaban99$76,468
Soliqua 100-33Insulin Glargine/Lixisenatide77$65,465
TrulicityDulaglutide37$61,022
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog41$48,312
LinzessLinaclotide48$41,618
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$37,285
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog41$33,314
MyrbetriqMirabegron51$33,138
Tresiba Flextouch U-200Insulin Degludec30$30,702
JanuviaSitagliptin Phosphate23$30,249
EntrestoSacubitril/Valsartan37$28,832
Invega SustennaPaliperidone Palmitate12$26,639

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$363$168,643180 claims
Johnson & JohnsonXarelto, Invega Sustenna, Invokana$86$114,446131 claims
Novo NordiskOzempic, Rybelsus$592$113,39893 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$80$65,46577 claims
AstraZenecaFarxiga, Symbicort$70$37,90674 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,818 pediatrics providers in North Carolina.

Other pediatrics in Salisbury

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →